US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Neurocrine Biosciences

152.57

-0.3600-0.24%

Post-market: 152.570.00000.00%19:43 EDT

Volume:1.23M

Turnover:188.30M

Market Cap:15.56B

PE:22.36

High:155.27

Open:153.13

Low:152.51

Close:152.93

52wk High:186.12

52wk Low:122.14

Shares:102.00M

Float Shares:100.00M

Volume Ratio:1.11

T/O Rate:1.23%

Dividend:- -

Dividend Rate:- -

EPS(TTM):6.82

EPS(LYR):4.67

ROE:22.09%

ROA:11.70%

PB:4.21

PE(LYR):32.67

Loading ...

Overview Company News Filings

Neurocrine Biosciences Late-Stage Study Shows Promising Results for Tardive Dyskinesia Drug

MT Newswires Live

Neurocrine reports new post-hoc data from KINECT 4 trial

Neurocrine says post-hoc KINECT 4 data show 94% response or remission with Ingrezza in tardive dyskinesia

Neurocrine Biosciences Presents New Clinically Meaningful Response Data on Treatment of Tardive Dyskinesia, Reinforcing the Efficacy of Ingrezza® (Valbenazine) Capsules Across a Broad Range of Patients

THOMSON REUTERS

Neurocrine presents new data showing Improvements with INGREZZA

Neurocrine says clinician-reported analysis shows rapid TD improvement with Ingrezza in patients with developmental disabilities

Neurocrine Biosciences CHRO Julie Cooke disposes of common shares worth $5.78 million

Movement Alert｜Neurocrine Biosciences Rises 5.85% in Regular Trading, RBC Raises Target Price on Crenessity Commercial Outlook

Neurocrine Biosciences CSO Jude Onyia disposes of common shares worth $1.76 million

Neurocrine Biosciences Chief Regulatory Officer Ingrid Delaet disposes of 2,261 common shares for $354,323.31

Neurocrine reinstated with a Buy at Goldman Sachs

Centene, Deckers and 14 Other 'Dividend Hopefuls' -- Barrons.com

Neurocrine Biosciences CSO Jude Onyia sells 11,000 shares for $1.71 million

Neurocrine Biosciences Should See More Upside on Crenessity Growth, RBC Says

MT Newswires Live

RBC Lifts Price Target on Neurocrine Biosciences to $183 From $180, Keeps Outperform Rating

MT Newswires Live

Neurocrine Chief Corporate Affairs Officer David W. Boyer disposes of 3,888 shares worth $609,019.12

Neurocrine Biosciences shareholders approved amended 2025 equity incentive plan at annual meeting

Beyond Next Ventures leads SCOHIA PHARMA private funding round raising JPY 3 billion

New Real‑World INGREZZA Data in Mild TD Might Change The Case For Investing In Neurocrine Biosciences (NBIX)

Simply Wall St.

Neurocrine executives to speak at William Blair growth stock conference

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/NBIX/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"NBIX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NBIX\",,,,,undefined,":{"symbol":"NBIX","market":"US","secType":"STK","nameCN":"Neurocrine Biosciences","latestPrice":152.57,"timestamp":1787342400000,"preClose":152.93,"halted":0,"volume":1227625,"hourTrading":{"tag":"盘后","latestPrice":152.57,"preClose":152.57,"latestTime":"19:43 EDT","volume":42081,"amount":6434214.421,"timestamp":1787355831826,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0023540181782515765,"floatShares":99995570,"shares":102000000,"eps":6.823004,"marketStatus":"Not Yet Opened","change":-0.36,"latestTime":"08-21 16:00:00 EDT","open":153.13,"high":155.265,"low":152.51,"amount":188300831.98499998,"amplitude":0.018015,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":6.823004,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":832824000000,"exchange":"NASDAQ","adjPreClose":152.93,"preHourTrading":{"tag":"盘前","latestPrice":152.93,"preClose":152.93,"latestTime":"09:25 EDT","volume":27,"amount":4168.59129,"timestamp":1787318735001,"change":0,"changeRate":0,"amplitude":0.051527},"postHourTrading":{"tag":"盘后","latestPrice":152.57,"preClose":152.57,"latestTime":"19:43 EDT","volume":42081,"amount":6434214.421,"timestamp":1787355831826,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.1069192222404156,"impliedVol":0.2965,"impliedVolPercentile":0.2191},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NBIX\",,,,,undefined,":{"symbol":"NBIX","floatShares":99995570,"roa":"11.70%","roe":"22.09%","lyrEps":4.67,"volumeRatio":1.1069192222404156,"shares":102000000,"dividePrice":0,"high":155.265,"amplitude":0.018015,"preClose":152.93,"low":152.51,"week52Low":122.1375,"pbRate":"4.21","psRate":"4.61","week52High":186.12,"institutionHeld":0.9909,"latestPrice":152.57,"eps":6.823004,"divideRate":0,"volume":1227625,"delay":0,"ttmEps":6.823004,"open":153.13,"prevYearClose":141.83,"prevWeekClose":152.72,"prevMonthClose":166.8,"prevQuarterClose":168.535,"fiveDayClose":152.72,"twentyDayClose":175.77,"sixtyDayClose":155.83},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NBIX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-07-30","symbol":"NBIX","fiscalQuarterEnding":"2026/06","expectedEps":1.88,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785384000000,"reportTimeType":"post","actualEps":2.36},{"market":"US","date":"2026-05-05","symbol":"NBIX","fiscalQuarterEnding":"2026/03","expectedEps":1.28,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1777953600000,"reportTimeType":"post","actualEps":1.41},{"market":"US","date":"2026-02-11","symbol":"NBIX","fiscalQuarterEnding":"2025/12","expectedEps":1.78,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1770786000000,"reportTimeType":"post","actualEps":1.43},{"market":"US","date":"2025-10-28","symbol":"NBIX","fiscalQuarterEnding":"2025/09","expectedEps":1.58,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1761624000000,"reportTimeType":"post","actualEps":2.04},{"market":"US","date":"2025-07-30","symbol":"NBIX","fiscalQuarterEnding":"2025/06","expectedEps":0.98,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1753848000000,"reportTimeType":"post","actualEps":1.06}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NBIX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NBIX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.4667,"hold":0.1333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4667,"analysts":30,"updateTime":1780459200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NBIX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NBIX","date":"2026-08-21","current":22.361118,"percent":0.059446,"low":15.452095,"twenty":27.727905,"median":40.453654,"eighty":110.387029,"high":905.986584,"avg":99.923304,"sd":176.088721,"marketCap":15545209250},"quantilePoints":[{"date":"2021-08-27","current":24.711359,"twenty":-58.891511,"median":21.503477,"eighty":264.839255,"marketCap":9012232778},{"date":"2021-09-03","current":24.880046,"twenty":-57.788755,"median":21.578659,"eighty":264.839255,"marketCap":9073752956},{"date":"2021-09-10","current":25.105828,"twenty":-57.393419,"median":21.731847,"eighty":264.839255,"marketCap":9156095347},{"date":"2021-09-17","current":25.043543,"twenty":-57.122936,"median":21.874823,"eighty":264.839255,"marketCap":9133380205},{"date":"2021-09-24","current":24.65167,"twenty":-56.515676,"median":21.983228,"eighty":264.839255,"marketCap":8990464100},{"date":"2021-10-01","current":26.330755,"twenty":-56.073302,"median":22.061434,"eighty":264.839255,"marketCap":9602826483},{"date":"2021-10-08","current":27.010694,"twenty":-54.272284,"median":22.130844,"eighty":264.839255,"marketCap":9850800122},{"date":"2021-10-15","current":27.130073,"twenty":-53.483205,"median":22.199493,"eighty":264.839255,"marketCap":9894337478},{"date":"2021-10-22","current":26.870554,"twenty":-53.14751,"median":22.365311,"eighty":264.839255,"marketCap":9799691051},{"date":"2021-10-29","current":27.355854,"twenty":-53.059611,"median":22.416552,"eighty":264.839255,"marketCap":9976679870},{"date":"2021-11-05","current":19.879776,"twenty":-52.91578,"median":22.430689,"eighty":264.839255,"marketCap":8842524454},{"date":"2021-11-12","current":18.76859,"twenty":-52.59512,"median":22.430689,"eighty":264.839255,"marketCap":8348268984},{"date":"2021-11-19","current":18.346297,"twenty":-52.419753,"median":22.430689,"eighty":264.839255,"marketCap":8160432931},{"date":"2021-11-26","current":18.551045,"twenty":-52.090504,"median":22.430689,"eighty":264.839255,"marketCap":8251504957},{"date":"2021-12-03","current":16.994105,"twenty":-51.971325,"median":22.430689,"eighty":264.839255,"marketCap":7558978098},{"date":"2021-12-10","current":16.987707,"twenty":-51.971325,"median":22.430689,"eighty":264.839255,"marketCap":7556132097},{"date":"2021-12-17","current":18.476398,"twenty":-51.971325,"median":22.430689,"eighty":264.839255,"marketCap":8218301614},{"date":"2021-12-23","current":18.147947,"twenty":-51.971325,"median":22.430689,"eighty":264.839255,"marketCap":8072206907},{"date":"2021-12-31","current":18.16501,"twenty":-51.971325,"median":22.430689,"eighty":264.839255,"marketCap":8079796242},{"date":"2022-01-07","current":16.064207,"twenty":-51.955042,"median":22.42362,"eighty":264.609771,"marketCap":7145359316},{"date":"2022-01-14","current":16.712577,"twenty":-51.955042,"median":22.42362,"eighty":264.609771,"marketCap":7433754063},{"date":"2022-01-21","current":16.017286,"twenty":-51.955042,"median":22.42362,"eighty":264.609771,"marketCap":7124488644},{"date":"2022-01-28","current":16.364931,"twenty":-51.955042,"median":22.42362,"eighty":264.609771,"marketCap":7279121353},{"date":"2022-02-04","current":17.305493,"twenty":-51.955042,"median":22.42362,"eighty":264.609771,"marketCap":7697483470},{"date":"2022-02-11","current":90.557458,"twenty":-51.955042,"median":22.431842,"eighty":264.609771,"marketCap":8113948252},{"date":"2022-02-18","current":90.693144,"twenty":-51.955042,"median":22.522526,"eighty":264.609771,"marketCap":8126105713},{"date":"2022-02-25","current":94.45608,"twenty":-51.955042,"median":22.586516,"eighty":264.609771,"marketCap":8463264811},{"date":"2022-03-04","current":93.743886,"twenty":-51.955042,"median":22.661461,"eighty":264.609771,"marketCap":8399452213},{"date":"2022-03-11","current":94.91316,"twenty":-51.955042,"median":22.80063,"eighty":264.609771,"marketCap":8504219165},{"date":"2022-03-18","current":98.99499,"twenty":-51.908672,"median":22.903884,"eighty":264.609771,"marketCap":8869951067},{"date":"2022-03-25","current":99.622146,"twenty":-51.908672,"median":23.045631,"eighty":264.609771,"marketCap":8926144250},{"date":"2022-04-01","current":101.588652,"twenty":-51.908672,"median":23.1378,"eighty":264.609771,"marketCap":9102343214},{"date":"2022-04-08","current":106.372046,"twenty":-51.908672,"median":23.19199,"eighty":264.609771,"marketCap":9530935287},{"date":"2022-04-14","current":105.521665,"twenty":-51.879725,"median":23.286066,"eighty":264.609771,"marketCap":9454741141},{"date":"2022-04-22","current":99.794282,"twenty":-51.235376,"median":23.504791,"eighty":264.609771,"marketCap":8941567652},{"date":"2022-04-29","current":95.96752,"twenty":-50.869461,"median":23.733072,"eighty":264.609771,"marketCap":8598689764},{"date":"2022-05-06","current":106.411117,"twenty":-50.538701,"median":24.05378,"eighty":264.609771,"marketCap":7597753757},{"date":"2022-05-13","current":112.603765,"twenty":-50.513367,"median":24.270178,"eighty":264.609771,"marketCap":8039908807},{"date":"2022-05-20","current":115.361299,"twenty":-50.513367,"median":24.572517,"eighty":264.609771,"marketCap":8236796731},{"date":"2022-05-27","current":124.624471,"twenty":-50.513367,"median":24.659455,"eighty":264.609771,"marketCap":8898187232},{"date":"2022-06-03","current":127.890676,"twenty":-50.513367,"median":24.724335,"eighty":264.609771,"marketCap":9131394287},{"date":"2022-06-10","current":126.244188,"twenty":-50.513367,"median":24.885236,"eighty":264.609771,"marketCap":9013834993},{"date":"2022-06-17","current":124.865421,"twenty":-50.513367,"median":25.0449,"eighty":264.609771,"marketCap":8915391031},{"date":"2022-06-24","current":131.50492,"twenty":-50.518997,"median":25.258455,"eighty":264.839255,"marketCap":9389451274},{"date":"2022-07-01","current":132.856915,"twenty":-50.518997,"median":25.998572,"eighty":264.839255,"marketCap":9485983703},{"date":"2022-07-08","current":127.930835,"twenty":-50.518997,"median":26.276232,"eighty":264.839255,"marketCap":9134261587},{"date":"2022-07-15","current":127.395391,"twenty":-50.518997,"median":26.439753,"eighty":264.839255,"marketCap":9096030922},{"date":"2022-07-22","current":127.556024,"twenty":-50.518997,"median":26.634392,"eighty":264.839255,"marketCap":9107500121},{"date":"2022-07-29","current":126.003238,"twenty":-50.518997,"median":26.826436,"eighty":264.839255,"marketCap":8996631194},{"date":"2022-08-05","current":815.065239,"twenty":-50.518997,"median":26.995123,"eighty":267.473329,"marketCap":9943795914},{"date":"2022-08-12","current":828.064055,"twenty":-50.518997,"median":27.355854,"eighty":332.018448,"marketCap":10102381477},{"date":"2022-08-19","current":838.803881,"twenty":-50.518997,"median":43.704114,"eighty":339.430085,"marketCap":10233407347},{"date":"2022-08-26","current":822.106196,"twenty":-50.518997,"median":44.350706,"eighty":343.175456,"marketCap":10029695593},{"date":"2022-09-02","current":807.525119,"twenty":-50.518997,"median":44.8698,"eighty":348.23866,"marketCap":9851806456},{"date":"2022-09-09","current":834.962629,"twenty":-50.518997,"median":45.079259,"eighty":349.917301,"marketCap":10186544079},{"date":"2022-09-16","current":831.670128,"twenty":-50.518997,"median":45.502731,"eighty":362.813526,"marketCap":10146375564},{"date":"2022-09-23","current":811.366371,"twenty":-50.518997,"median":45.962631,"eighty":364.154541,"marketCap":9898669723},{"date":"2022-09-30","current":832.610843,"twenty":-50.518997,"median":46.285926,"eighty":365.308101,"marketCap":10157852283},{"date":"2022-10-07","current":848.602992,"twenty":-50.518997,"median":47.210279,"eighty":371.273896,"marketCap":10352956498},{"date":"2022-10-14","current":848.446206,"twenty":-50.518997,"median":49.327638,"eighty":378.797857,"marketCap":10351043711},{"date":"2022-10-21","current":869.690678,"twenty":-50.518997,"median":50.903135,"eighty":389.463975,"marketCap":10610226271},{"date":"2022-10-28","current":905.986584,"twenty":-50.518997,"median":51.513299,"eighty":431.928138,"marketCap":11053036327},{"date":"2022-11-04","current":201.221497,"twenty":-50.458475,"median":52.087035,"eighty":434.881702,"marketCap":11711091146},{"date":"2022-11-11","current":200.593816,"twenty":-50.126307,"median":52.792822,"eighty":434.881702,"marketCap":11674560078},{"date":"2022-11-18","current":198.47952,"twenty":-49.947556,"median":54.395533,"eighty":434.881702,"marketCap":11551508062},{"date":"2022-11-25","current":201.766589,"twenty":-49.629464,"median":57.560591,"eighty":434.881702,"marketCap":11742815494},{"date":"2022-12-02","current":209.463947,"twenty":-49.385812,"median":59.991394,"eighty":434.881702,"marketCap":12190801742},{"date":"2022-12-09","current":193.656283,"twenty":-48.929381,"median":62.264354,"eighty":434.881702,"marketCap":11270795649},{"date":"2022-12-16","current":193.573693,"twenty":-48.286719,"median":62.627396,"eighty":434.881702,"marketCap":11265988929},{"date":"2022-12-23","current":198.727289,"twenty":-40.846451,"median":63.253512,"eighty":434.881702,"marketCap":11565928220},{"date":"2022-12-30","current":197.290229,"twenty":-39.648276,"median":63.753352,"eighty":434.881702,"marketCap":11482291302},{"date":"2023-01-06","current":203.20365,"twenty":-39.648276,"median":64.910878,"eighty":434.881702,"marketCap":11826452411},{"date":"2023-01-13","current":180.028985,"twenty":-39.648276,"median":65.66327,"eighty":434.881702,"marketCap":10477686948},{"date":"2023-01-20","current":183.943736,"twenty":-39.648276,"median":66.031573,"eighty":434.881702,"marketCap":10705525447},{"date":"2023-01-27","current":178.806658,"twenty":-37.833689,"median":67.168053,"eighty":434.881702,"marketCap":10406547501},{"date":"2023-02-03","current":181.746851,"twenty":-35.951624,"median":67.783646,"eighty":434.881702,"marketCap":10577666711},{"date":"2023-02-10","current":64.510722,"twenty":15.966099,"median":67.783646,"eighty":434.881702,"marketCap":9966906536},{"date":"2023-02-17","current":64.729529,"twenty":16.188336,"median":67.783646,"eighty":434.881702,"marketCap":10000712304},{"date":"2023-02-24","current":64.0481,"twenty":16.573519,"median":67.783646,"eighty":434.881702,"marketCap":9895431481},{"date":"2023-03-03","current":63.254141,"twenty":16.938226,"median":67.783646,"eighty":434.881702,"marketCap":9772764834},{"date":"2023-03-10","current":59.897008,"twenty":17.137429,"median":67.783646,"eighty":434.881702,"marketCap":9254087752},{"date":"2023-03-17","current":58.921752,"twenty":17.302081,"median":67.783646,"eighty":434.881702,"marketCap":9103410611},{"date":"2023-03-24","current":60.672212,"twenty":17.624986,"median":67.783646,"eighty":434.881702,"marketCap":9373856762},{"date":"2023-03-31","current":63.279148,"twenty":17.970498,"median":67.68894,"eighty":434.086512,"marketCap":9776628351},{"date":"2023-04-06","current":63.898061,"twenty":18.054957,"median":67.68894,"eighty":434.086512,"marketCap":9872250383},{"date":"2023-04-14","current":64.873317,"twenty":18.158185,"median":67.783646,"eighty":434.881702,"marketCap":10022927524},{"date":"2023-04-21","current":65.367197,"twenty":18.484076,"median":67.783646,"eighty":434.881702,"marketCap":10099231974},{"date":"2023-04-28","current":63.70426,"twenty":18.731906,"median":67.783646,"eighty":434.881702,"marketCap":9842308130},{"date":"2023-05-05","current":146.11832,"twenty":19.078272,"median":68.588653,"eighty":434.881702,"marketCap":9351572473},{"date":"2023-05-12","current":149.137041,"twenty":19.909208,"median":69.22003,"eighty":434.881702,"marketCap":9544770653},{"date":"2023-05-19","current":144.639451,"twenty":20.507993,"median":87.443915,"eighty":434.881702,"marketCap":9256924881},{"date":"2023-05-26","current":140.538259,"twenty":21.155662,"median":90.238157,"eighty":434.881702,"marketCap":8994448566},{"date":"2023-06-02","current":139.028898,"twenty":21.398536,"median":90.937629,"eighty":434.881702,"marketCap":8897849477},{"date":"2023-06-09","current":143.358782,"twenty":21.506213,"median":91.668604,"eighty":434.881702,"marketCap":9174962017},{"date":"2023-06-16","current":147.658173,"twenty":21.60402,"median":92.617131,"eighty":434.881702,"marketCap":9450123060},{"date":"2023-06-23","current":149.18278,"twenty":21.770569,"median":93.488972,"eighty":435.676893,"marketCap":9547697898},{"date":"2023-06-30","current":144.060101,"twenty":21.895923,"median":94.02934,"eighty":436.472083,"marketCap":9219846442},{"date":"2023-07-07","current":143.922886,"twenty":21.989585,"median":94.91316,"eighty":436.472083,"marketCap":9211064707},{"date":"2023-07-14","current":146.407995,"twenty":22.061764,"median":95.529687,"eighty":436.472083,"marketCap":9370111693},{"date":"2023-07-21","current":149.274256,"twenty":22.130933,"median":95.839905,"eighty":436.472083,"marketCap":9553552388},{"date":"2023-07-28","current":154.366443,"twenty":22.209371,"median":96.635182,"eighty":436.472083,"marketCap":9879452347},{"date":"2023-08-04","current":57.179827,"twenty":22.369622,"median":96.794628,"eighty":436.472083,"marketCap":10086521560},{"date":"2023-08-11","current":57.938239,"twenty":22.419379,"median":96.794628,"eighty":436.472083,"marketCap":10220305417},{"date":"2023-08-18","current":57.738949,"twenty":22.500257,"median":96.794628,"eighty":436.472083,"marketCap":10185150535},{"date":"2023-08-25","current":59.27238,"twenty":22.577261,"median":96.794628,"eighty":436.472083,"marketCap":10455647821},{"date":"2023-09-01","current":60.279905,"twenty":22.655218,"median":96.794628,"eighty":436.472083,"marketCap":10633375280},{"date":"2023-09-08","current":60.052935,"twenty":22.776647,"median":96.794628,"eighty":436.472083,"marketCap":10593337776},{"date":"2023-09-15","current":62.986937,"twenty":22.862726,"median":96.982474,"eighty":437.267273,"marketCap":11110895761},{"date":"2023-09-22","current":62.616035,"twenty":22.973265,"median":96.982474,"eighty":437.267273,"marketCap":11045468619},{"date":"2023-09-29","current":63.750885,"twenty":23.123786,"median":96.982474,"eighty":437.267273,"marketCap":11245656142},{"date":"2023-10-06","current":63.828387,"twenty":23.187287,"median":96.982474,"eighty":437.267273,"marketCap":11259327485},{"date":"2023-10-13","current":61.580831,"twenty":23.281362,"median":96.982474,"eighty":437.267273,"marketCap":10862858538},{"date":"2023-10-20","current":61.519936,"twenty":23.429531,"median":96.982474,"eighty":437.267273,"marketCap":10852116768},{"date":"2023-10-27","current":59.742927,"twenty":23.646846,"median":97.20033,"eighty":438.237231,"marketCap":10538652404},{"date":"2023-11-03","current":58.32872,"twenty":23.985048,"median":97.20033,"eighty":438.237231,"marketCap":11140785548},{"date":"2023-11-10","current":57.690854,"twenty":23.985048,"median":95.96752,"eighty":392.709437,"marketCap":11018953164},{"date":"2023-11-17","current":55.952155,"twenty":23.985048,"median":95.589827,"eighty":383.351833,"marketCap":10686861664},{"date":"2023-11-24","current":57.701142,"twenty":23.985048,"median":95.489796,"eighty":377.211039,"marketCap":11020918202},{"date":"2023-12-01","current":59.974826,"twenty":23.985048,"median":94.859599,"eighty":367.477481,"marketCap":11455191702},{"date":"2023-12-08","current":61.728957,"twenty":24.007626,"median":93.696554,"eighty":365.084276,"marketCap":11790230760},{"date":"2023-12-15","current":62.423408,"twenty":24.007626,"median":93.180509,"eighty":363.965151,"marketCap":11922870856},{"date":"2023-12-22","current":62.32567,"twenty":24.007626,"median":91.967766,"eighty":361.900364,"marketCap":11904202990},{"date":"2023-12-29","current":67.979014,"twenty":23.985048,"median":91.60565,"eighty":350.289361,"marketCap":12983991624},{"date":"2024-01-05","current":68.714617,"twenty":23.96247,"median":91.018028,"eighty":348.300433,"marketCap":13124491874},{"date":"2024-01-12","current":67.171393,"twenty":23.96247,"median":90.125498,"eighty":344.013234,"marketCap":12829736105},{"date":"2024-01-19","current":70.34529,"twenty":23.939892,"median":87.443915,"eighty":339.611278,"marketCap":13435950470},{"date":"2024-01-26","current":72.536668,"twenty":23.96247,"median":71.993968,"eighty":332.715749,"marketCap":13854503662},{"date":"2024-02-02","current":73.277416,"twenty":23.96247,"median":71.906519,"eighty":313.773789,"marketCap":13995986431},{"date":"2024-02-09","current":52.891564,"twenty":23.96247,"median":70.886562,"eighty":261.06275,"marketCap":13207023489},{"date":"2024-02-16","current":53.400095,"twenty":23.96247,"median":69.696194,"eighty":257.160449,"marketCap":13334003660},{"date":"2024-02-23","current":53.149035,"twenty":23.96247,"median":68.840647,"eighty":255.027964,"marketCap":13271313941},{"date":"2024-03-01","current":51.965465,"twenty":23.985048,"median":68.588653,"eighty":248.779166,"marketCap":12975776696},{"date":"2024-03-08","current":53.930111,"twenty":23.985048,"median":68.148768,"eighty":244.412047,"marketCap":13466348621},{"date":"2024-03-15","current":55.456397,"twenty":23.985048,"median":67.762962,"eighty":240.453561,"marketCap":13847462308},{"date":"2024-03-22","current":57.281564,"twenty":23.985048,"median":67.173314,"eighty":238.312647,"marketCap":14303206612},{"date":"2024-03-28","current":54.926381,"twenty":23.985048,"median":66.336739,"eighty":235.829511,"marketCap":13715117346},{"date":"2024-04-05","current":54.838709,"twenty":23.96247,"median":65.960543,"eighty":230.641182,"marketCap":13693225698},{"date":"2024-04-12","current":54.753332,"twenty":23.96247,"median":65.52974,"eighty":224.225614,"marketCap":13671906957},{"date":"2024-04-19","current":53.387822,"twenty":23.96247,"median":65.224959,"eighty":214.926531,"marketCap":13330939072},{"date":"2024-04-26","current":55.490466,"twenty":23.985048,"median":65.016713,"eighty":211.299293,"marketCap":13855969266},{"date":"2024-05-03","current":38.063574,"twenty":24.176232,"median":64.926662,"eighty":209.711716,"marketCap":14072103451},{"date":"2024-05-10","current":38.017298,"twenty":24.502187,"median":64.926662,"eighty":209.711716,"marketCap":14054995122},{"date":"2024-05-17","current":38.629778,"twenty":24.632825,"median":64.926662,"eighty":209.711716,"marketCap":14281428883},{"date":"2024-05-24","current":38.248679,"twenty":24.716549,"median":64.926662,"eighty":209.711716,"marketCap":14140536765},{"date":"2024-05-31","current":37.200658,"twenty":24.820876,"median":64.926662,"eighty":209.711716,"marketCap":13753083441},{"date":"2024-06-07","current":36.223413,"twenty":24.997349,"median":64.926662,"eighty":209.711716,"marketCap":13391795796},{"date":"2024-06-14","current":37.091773,"twenty":25.132663,"median":64.971688,"eighty":209.794306,"marketCap":13712828551},{"date":"2024-06-21","current":36.495626,"twenty":25.611349,"median":65.016713,"eighty":209.876896,"marketCap":13492433023},{"date":"2024-06-28","current":36.560957,"twenty":26.148895,"median":65.029383,"eighty":211.299293,"marketCap":13516585958},{"date":"2024-07-05","current":37.628033,"twenty":26.322584,"median":65.029383,"eighty":211.299293,"marketCap":13911083888},{"date":"2024-07-12","current":39.879237,"twenty":26.601174,"median":65.029383,"eighty":211.299293,"marketCap":14743353755},{"date":"2024-07-15","current":40.131034,"twenty":26.615894,"median":65.029383,"eighty":211.299293,"marketCap":14836443190},{"date":"2024-08-02","current":45.591134,"twenty":26.86173,"median":65.123383,"eighty":209.546537,"marketCap":15464512534},{"date":"2024-08-09","current":43.679968,"twenty":26.86173,"median":64.926662,"eighty":203.758652,"marketCap":14816245015},{"date":"2024-08-16","current":43.989565,"twenty":26.86173,"median":64.824841,"eighty":201.969234,"marketCap":14921260314},{"date":"2024-08-23","current":45.418474,"twenty":26.86173,"median":64.529477,"eighty":201.100989,"marketCap":15405946309},{"date":"2024-08-30","current":38.232251,"twenty":26.86173,"median":64.341928,"eighty":199.724972,"marketCap":12968379659},{"date":"2024-09-06","current":36.082934,"twenty":26.86173,"median":64.216895,"eighty":198.7372,"marketCap":12239331141},{"date":"2024-09-13","current":36.103772,"twenty":26.86173,"median":63.998087,"eighty":198.373805,"marketCap":12246399478},{"date":"2024-09-20","current":35.859667,"twenty":26.86173,"median":63.828387,"eighty":196.979242,"marketCap":12163598954},{"date":"2024-09-27","current":34.511134,"twenty":26.86173,"median":63.679253,"eighty":196.20378,"marketCap":11706176546},{"date":"2024-10-04","current":33.305492,"twenty":26.86173,"median":63.327173,"eighty":193.88423,"marketCap":11297222738},{"date":"2024-10-11","current":33.463267,"twenty":26.86173,"median":63.274802,"eighty":189.672156,"marketCap":11350740150},{"date":"2024-10-18","current":35.264288,"twenty":26.86173,"median":63.195636,"eighty":182.652034,"marketCap":11961646456},{"date":"2024-10-25","current":34.389081,"twenty":26.86173,"median":62.986937,"eighty":181.026669,"marketCap":11664776284},{"date":"2024-10-31","current":32.619923,"twenty":26.86173,"median":62.892828,"eighty":179.513625,"marketCap":12588028444},{"date":"2024-11-08","current":32.528095,"twenty":26.852907,"median":62.621935,"eighty":178.558889,"marketCap":12552592025},{"date":"2024-11-15","current":32.238181,"twenty":26.852907,"median":62.553735,"eighty":154.18349,"marketCap":12440714189},{"date":"2024-11-22","current":32.795708,"twenty":26.852907,"median":62.388604,"eighty":149.95728,"marketCap":12655863875},{"date":"2024-11-29","current":33.254848,"twenty":26.852907,"median":62.257511,"eighty":149.213272,"marketCap":12833045969},{"date":"2024-12-06","current":33.168268,"twenty":26.852907,"median":61.886863,"eighty":148.618675,"marketCap":12799634488},{"date":"2024-12-13","current":33.265343,"twenty":26.852907,"median":61.550384,"eighty":147.743551,"marketCap":12837095845},{"date":"2024-12-20","current":35.40887,"twenty":26.852907,"median":61.259752,"eighty":146.444586,"marketCap":13664283108},{"date":"2024-12-27","current":36.476699,"twenty":26.852907,"median":61.063228,"eighty":145.764611,"marketCap":14076358036},{"date":"2025-01-03","current":36.169731,"twenty":26.852907,"median":60.907571,"eighty":144.785813,"marketCap":13957899150},{"date":"2025-01-10","current":36.392742,"twenty":26.844083,"median":60.680648,"eighty":144.044855,"marketCap":14043959024},{"date":"2025-01-17","current":37.234935,"twenty":26.844083,"median":60.329767,"eighty":143.386225,"marketCap":14368961609},{"date":"2025-01-24","current":38.719925,"twenty":26.844083,"median":60.247462,"eighty":142.678807,"marketCap":14942019125},{"date":"2025-01-31","current":40.218033,"twenty":26.844083,"median":59.974826,"eighty":141.016986,"marketCap":15520138987},{"date":"2025-02-07","current":44.648909,"twenty":26.844083,"median":59.754628,"eighty":137.028614,"marketCap":15238672574},{"date":"2025-02-14","current":34.141082,"twenty":26.844083,"median":59.521493,"eighty":131.55311,"marketCap":11652351200},{"date":"2025-02-21","current":33.919064,"twenty":26.844083,"median":59.27238,"eighty":130.444741,"marketCap":11576576519},{"date":"2025-02-28","current":34.328044,"twenty":26.844083,"median":59.040533,"eighty":129.095424,"marketCap":11716161457},{"date":"2025-03-07","current":32.91122,"twenty":26.83526,"median":58.73161,"eighty":127.751461,"marketCap":11232599351},{"date":"2025-03-14","current":31.839108,"twenty":26.83526,"median":58.3673,"eighty":127.30972,"marketCap":10866687407},{"date":"2025-03-21","current":32.154607,"twenty":26.83526,"median":57.889136,"eighty":126.142453,"marketCap":10974367216},{"date":"2025-03-28","current":33.302672,"twenty":26.83526,"median":57.695998,"eighty":125.695358,"marketCap":11366202078},{"date":"2025-04-04","current":30.054201,"twenty":26.83526,"median":57.273606,"eighty":124.678015,"marketCap":10257498857},{"date":"2025-04-11","current":26.501916,"twenty":26.750137,"median":56.720224,"eighty":122.876248,"marketCap":9045103969},{"date":"2025-04-17","current":29.242083,"twenty":26.695569,"median":56.384258,"eighty":119.27935,"marketCap":9980323052},{"date":"2025-04-25","current":30.658387,"twenty":26.680493,"median":56.257145,"eighty":115.693273,"marketCap":10463707627},{"date":"2025-05-02","current":30.898993,"twenty":26.680493,"median":56.044889,"eighty":114.003704,"marketCap":10545826362},{"date":"2025-05-09","current":38.032908,"twenty":26.680493,"median":55.948895,"eighty":113.591967,"marketCap":11630463166},{"date":"2025-05-16","current":38.922888,"twenty":26.680493,"median":55.567979,"eighty":113.591967,"marketCap":11902619171},{"date":"2025-05-23","current":38.550714,"twenty":26.680493,"median":55.400605,"eighty":113.591967,"marketCap":11788808478},{"date":"2025-05-30","current":40.019991,"twenty":26.680493,"median":55.045675,"eighty":113.591967,"marketCap":12238113301},{"date":"2025-06-06","current":40.327439,"twenty":26.680493,"median":54.834724,"eighty":113.591967,"marketCap":12332130830},{"date":"2025-06-13","current":40.456891,"twenty":26.680493,"median":54.478076,"eighty":113.591967,"marketCap":12371717158},{"date":"2025-06-20","current":41.201238,"twenty":26.665418,"median":53.930111,"eighty":113.621107,"marketCap":12599338544},{"date":"2025-06-27","current":41.00706,"twenty":26.665418,"median":53.569084,"eighty":113.621107,"marketCap":12539959052},{"date":"2025-07-03","current":41.783771,"twenty":26.665418,"median":53.336333,"eighty":113.621107,"marketCap":12777477020},{"date":"2025-07-11","current":43.664056,"twenty":26.665418,"median":53.065577,"eighty":113.621107,"marketCap":13352468434},{"date":"2025-07-18","current":43.401917,"twenty":26.665418,"median":52.829249,"eighty":113.621107,"marketCap":13272306120},{"date":"2025-07-25","current":42.602552,"twenty":26.665418,"median":52.511422,"eighty":113.621107,"marketCap":13027860544},{"date":"2025-08-01","current":36.514628,"twenty":26.665418,"median":52.087035,"eighty":113.621107,"marketCap":12718045027},{"date":"2025-08-08","current":35.765712,"twenty":26.665418,"median":51.986859,"eighty":113.621107,"marketCap":12457197656},{"date":"2025-08-15","current":37.391686,"twenty":26.665418,"median":51.677224,"eighty":113.621107,"marketCap":13023524078},{"date":"2025-08-22","current":38.522178,"twenty":26.665418,"median":50.766532,"eighty":113.621107,"marketCap":13417274672},{"date":"2025-08-29","current":39.564396,"twenty":26.665418,"median":49.022556,"eighty":113.621107,"marketCap":13780278999},{"date":"2025-09-05","current":39.980144,"twenty":26.660526,"median":47.055461,"eighty":113.639848,"marketCap":13925084004},{"date":"2025-09-12","current":40.891372,"twenty":26.665418,"median":46.381549,"eighty":113.621107,"marketCap":14242464836},{"date":"2025-09-19","current":41.477975,"twenty":26.665418,"median":46.003612,"eighty":113.621107,"marketCap":14446778746},{"date":"2025-09-26","current":40.119675,"twenty":26.665418,"median":46.003612,"eighty":113.621107,"marketCap":13973682943},{"date":"2025-10-03","current":38.937926,"twenty":26.665418,"median":46.003612,"eighty":113.621107,"marketCap":13562079677},{"date":"2025-10-10","current":39.430559,"twenty":26.665418,"median":45.680316,"eighty":113.621107,"marketCap":13733663689},{"date":"2025-10-17","current":39.160038,"twenty":26.665418,"median":45.489919,"eighty":113.621107,"marketCap":13639441255},{"date":"2025-10-24","current":40.911305,"twenty":26.665418,"median":45.418474,"eighty":113.621107,"marketCap":14249407541},{"date":"2025-10-31","current":32.157417,"twenty":26.665418,"median":45.329167,"eighty":113.621107,"marketCap":13763374551},{"date":"2025-11-07","current":36.06178,"twenty":26.665418,"median":44.861795,"eighty":113.621107,"marketCap":15434442050},{"date":"2025-11-14","current":33.58428,"twenty":26.665418,"median":43.968726,"eighty":113.621107,"marketCap":14374071952},{"date":"2025-11-21","current":32.376397,"twenty":26.665418,"median":43.66806,"eighty":113.621107,"marketCap":13857097908},{"date":"2025-11-28","current":35.446773,"twenty":26.665418,"median":43.352509,"eighty":113.621107,"marketCap":15171219007},{"date":"2025-12-05","current":35.926665,"twenty":26.665418,"median":43.191558,"eighty":113.621107,"marketCap":15376612745},{"date":"2025-12-12","current":36.050133,"twenty":26.665418,"median":42.725532,"eighty":113.621107,"marketCap":15429456765},{"date":"2025-12-19","current":33.042655,"twenty":26.665418,"median":41.783771,"eighty":113.621107,"marketCap":14142256204},{"date":"2025-12-26","current":34.228407,"twenty":26.665418,"median":41.688697,"eighty":113.621107,"marketCap":14649758207},{"date":"2026-01-02","current":33.040325,"twenty":26.665418,"median":41.424542,"eighty":113.621107,"marketCap":14141259147},{"date":"2026-01-09","current":31.582013,"twenty":26.665418,"median":41.053684,"eighty":113.621107,"marketCap":13517101477},{"date":"2026-01-16","current":31.064848,"twenty":26.665418,"median":40.948324,"eighty":113.621107,"marketCap":13295754828},{"date":"2026-01-23","current":32.001336,"twenty":26.665418,"median":40.689904,"eighty":113.246297,"marketCap":13696571734},{"date":"2026-01-30","current":32.138781,"twenty":26.665418,"median":40.57987,"eighty":112.603765,"marketCap":13755398096},{"date":"2026-02-06","current":32.131792,"twenty":26.764151,"median":40.453654,"eighty":110.060408,"marketCap":13752406925},{"date":"2026-02-13","current":25.645156,"twenty":26.870554,"median":40.453654,"eighty":110.060408,"marketCap":12273771423},{"date":"2026-02-20","current":27.282254,"twenty":26.921566,"median":40.453654,"eighty":110.060408,"marketCap":13057286536},{"date":"2026-02-27","current":27.395493,"twenty":26.995123,"median":40.453654,"eighty":110.060408,"marketCap":13111482806},{"date":"2026-03-06","current":27.185791,"twenty":27.241002,"median":40.453654,"eighty":110.060408,"marketCap":13011119343},{"date":"2026-03-13","current":26.795744,"twenty":27.246604,"median":40.453654,"eighty":110.060408,"marketCap":12824443302},{"date":"2026-03-20","current":27.198373,"twenty":27.355854,"median":40.453654,"eighty":110.060408,"marketCap":13017141151},{"date":"2026-03-27","current":27.768763,"twenty":27.410172,"median":40.453654,"eighty":110.060408,"marketCap":13290129770},{"date":"2026-04-02","current":27.798121,"twenty":27.462597,"median":40.453654,"eighty":110.060408,"marketCap":13304180655},{"date":"2026-04-10","current":27.605195,"twenty":27.596807,"median":40.453654,"eighty":110.060408,"marketCap":13211846269},{"date":"2026-04-17","current":26.927857,"twenty":27.596807,"median":40.453654,"eighty":110.060408,"marketCap":12887672283},{"date":"2026-04-24","current":27.360571,"twenty":27.626165,"median":40.453654,"eighty":110.060408,"marketCap":13094769408},{"date":"2026-05-01","current":27.671606,"twenty":27.654794,"median":40.453654,"eighty":110.060408,"marketCap":13243630754},{"date":"2026-05-08","current":22.496668,"twenty":27.694724,"median":40.453654,"eighty":110.060408,"marketCap":15041271956},{"date":"2026-05-15","current":23.919346,"twenty":27.694724,"median":40.453654,"eighty":110.060408,"marketCap":15992474796},{"date":"2026-05-22","current":23.385466,"twenty":27.694724,"median":40.453654,"eighty":110.060408,"marketCap":15635522356},{"date":"2026-05-29","current":23.519312,"twenty":27.715019,"median":40.453654,"eighty":110.223718,"marketCap":15725011841},{"date":"2026-06-05","current":25.167574,"twenty":27.694724,"median":40.453654,"eighty":110.060408,"marketCap":16827039655},{"date":"2026-06-12","current":24.469769,"twenty":27.694724,"median":40.453654,"eighty":110.060408,"marketCap":16360487733},{"date":"2026-06-18","current":23.911827,"twenty":27.694724,"median":40.453654,"eighty":110.060408,"marketCap":15987447297},{"date":"2026-06-26","current":24.690841,"twenty":27.715019,"median":40.453654,"eighty":110.223718,"marketCap":16508296208},{"date":"2026-07-02","current":25.230737,"twenty":27.715019,"median":40.453654,"eighty":110.223718,"marketCap":16869270647},{"date":"2026-07-10","current":27.152706,"twenty":27.715019,"median":40.453654,"eighty":110.223718,"marketCap":18154299430},{"date":"2026-07-17","current":25.799207,"twenty":27.715019,"median":40.453654,"eighty":110.223718,"marketCap":17249349583},{"date":"2026-07-24","current":26.190218,"twenty":27.715019,"median":40.453654,"eighty":110.223718,"marketCap":17510779539},{"date":"2026-07-31","current":26.438018,"twenty":27.727905,"median":40.453654,"eighty":110.387029,"marketCap":18652021846},{"date":"2026-08-07","current":23.027033,"twenty":27.727905,"median":40.453654,"eighty":110.387029,"marketCap":16245572107},{"date":"2026-08-14","current":21.730304,"twenty":27.727905,"median":40.453654,"eighty":110.387029,"marketCap":15330729478},{"date":"2026-08-21","current":22.034315,"twenty":27.727905,"median":40.453654,"eighty":110.387029,"marketCap":15545209250}],"updateTime":1787515778071},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NBIX\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2642243256","title":"Neurocrine Biosciences Late-Stage Study Shows Promising Results for Tardive Dyskinesia Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2642243256","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642243256?lang=en_us&edition=fundamental","pubTime":"2026-06-09 05:38","pubTimestamp":1780954716,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences  said late Monday its drug INGREZZA, used to treat tardive dyskinesia, a movement disorder, showed a clinically meaningful response in a late-stage trial.The company said that after 48 weeks of treatment, 94% of patients achieved either symptomatic remission or clinically meaningful improvement in involuntary movements.A separate analysis found high hepatic risk factors in patients with tardive dyskinesia, the company said, adding that INGREZZA is the only VMAT2 inhibitor approved for use in patients with hepatic impairment.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0154245756.USD","NBIX","LU2065170008.USD","BK4139","LU0109394709.USD","LU0154245673.USD","LU2065171402.SGD","LU2065171311.SGD","LU0823416689.USD","LU2324357040.USD","LU0320765992.SGD","LU0889565916.HKD","LU2065169927.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642442431","title":"Neurocrine reports new post-hoc data from KINECT 4 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2642442431","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642442431?lang=en_us&edition=fundamental","pubTime":"2026-06-09 04:15","pubTimestamp":1780949711,"startTime":"0","endTime":"0","summary":"Neurocrine (NBIX) Biosciences announced new post-hoc data from the KINECT 4 clinical trial demonstrating that adults with tardive dyskinesia treate...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neurocrine-reports-new-post-hoc-data-from-kinect-4-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neurocrine-reports-new-post-hoc-data-from-kinect-4-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0154245673.USD","LU2065170008.USD","LU2065171402.SGD","LU0889565916.HKD","LU2065171311.SGD","NBIX","LU2324357040.USD","BK4139","LU0154245756.USD","LU0823416689.USD","LU2065169927.USD","LU0109394709.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642431304","title":"Neurocrine says post-hoc KINECT 4 data show 94% response or remission with Ingrezza in tardive dyskinesia","url":"https://stock-news.laohu8.com/highlight/detail?id=2642431304","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642431304?lang=en_us&edition=fundamental","pubTime":"2026-06-09 04:06","pubTimestamp":1780949161,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences flagged new post-hoc results from its 48-week KINECT 4 trial in tardive dyskinesia, presented at 2026 Psych Congress Elevate.The analysis showed most patients on Ingrezza reached either symptom remission or a meaningful improvement in involuntary movements over long-term treatment.Separately presented Medicare claims work found hepatic risk factors were common in newly diagnosed tardive dyskinesia, shaping treatment selection and dosing considerations.The update reinforces Ingrezza’s positioning across a broad patient mix, including those with potential liver impairment, a key differentiator within the VMAT2 inhibitor class.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nNDL2P8VGY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0154245756.USD","LU2065169927.USD","LU0889565916.HKD","BK4139","LU2065171402.SGD","LU0823416689.USD","LU2324357040.USD","LU0320765992.SGD","LU0109394709.USD","LU0154245673.USD","LU2065171311.SGD","LU2065170008.USD","NBIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642313754","title":"Neurocrine Biosciences Presents New Clinically Meaningful Response Data on Treatment of Tardive Dyskinesia, Reinforcing the Efficacy of Ingrezza® (Valbenazine) Capsules Across a Broad Range of Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2642313754","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642313754?lang=en_us&edition=fundamental","pubTime":"2026-06-09 04:05","pubTimestamp":1780949101,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nTUA4VMBP1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0154245756.USD","LU0889565916.HKD","LU0109394709.USD","BK4139","LU2065171402.SGD","LU0320765992.SGD","LU2065171311.SGD","LU0823416689.USD","LU2065170008.USD","NBIX","LU2324357040.USD","LU0154245673.USD","LU2065169927.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641484918","title":"Neurocrine presents new data showing Improvements with INGREZZA","url":"https://stock-news.laohu8.com/highlight/detail?id=2641484918","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641484918?lang=en_us&edition=fundamental","pubTime":"2026-06-08 20:33","pubTimestamp":1780922014,"startTime":"0","endTime":"0","summary":"Neurocrine (NBIX) Biosciences announced new clinician-reported data in patients with intellectual and developmental disabilities demonstrating mean...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neurocrine-presents-new-data-showing-improvements-with-ingrezza-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neurocrine-presents-new-data-showing-improvements-with-ingrezza-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","LU2065169927.USD","LU0154245673.USD","LU0109394709.USD","LU2065170008.USD","LU0823416689.USD","LU0154245756.USD","NBIX","LU2065171402.SGD","LU0320765992.SGD","LU2065171311.SGD","BK4139","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641948430","title":"Neurocrine says clinician-reported analysis shows rapid TD improvement with Ingrezza in patients with developmental disabilities","url":"https://stock-news.laohu8.com/highlight/detail?id=2641948430","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641948430?lang=en_us&edition=fundamental","pubTime":"2026-06-08 20:31","pubTimestamp":1780921862,"startTime":"0","endTime":"0","summary":"Neurocrine says clinician-reported analysis shows rapid TD improvement with Ingrezza in patients with developmental disabilities. Neurocrine Biosciences announced clinician-reported findings on Ingrezza in tardive dyskinesia patients with intellectual and developmental disabilities, presented June 8, 2026.Clinicians reported rapid easing of involuntary movements soon after treatment started, with most patients showing improvement within the first month.Reported gains extended beyond symptom control, with broad improvements in day-to-day functioning, including independence, social interaction, emotional well-being.The analysis covered 30 patients who began Ingrezza in early 2024, supporting the drug’s real-world profile in a higher-risk subgroup.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260608:nNDL7mmShC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU2065171311.SGD","NBIX","LU0823416689.USD","LU2324357040.USD","LU2065171402.SGD","LU0154245673.USD","LU0154245756.USD","LU2065169927.USD","LU0320765992.SGD","LU0109394709.USD","LU2065170008.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641160192","title":"Neurocrine Biosciences CHRO Julie Cooke disposes of common shares worth $5.78 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2641160192","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641160192?lang=en_us&edition=fundamental","pubTime":"2026-06-05 06:03","pubTimestamp":1780610605,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences Chief Human Resources Officer Julie Cooke exercised stock options for 24,965 shares at $81.49 on June 2, 2026.Cooke sold 36,937 shares on June 2 at weighted average prices ranging from $154.83 to $158.59.Beneficial ownership fell to 22,374 shares following the transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurocrine Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 04, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDL6VvDgS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Neurocrine Biosciences CHRO Julie Cooke disposes of common shares worth $5.78 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU0109394709.USD","LU2065169927.USD","LU0823416689.USD","LU0154245673.USD","LU2065171311.SGD","BK4139","LU0889565916.HKD","LU2065171402.SGD","LU0154245756.USD","LU2065170008.USD","LU2324357040.USD","NBIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109929363","title":"Movement Alert｜Neurocrine Biosciences Rises 5.85% in Regular Trading, RBC Raises Target Price on Crenessity Commercial Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=1109929363","media":"Market Focus","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109929363?lang=en_us&edition=fundamental","pubTime":"2026-06-04 00:17","pubTimestamp":1780503428,"startTime":"0","endTime":"0","summary":"On June 4, Neurocrine Biosciences rose 5.85% in regular trading, trading at $163.94/share, with trading volume of $89.26 million.On the news front, RBC Capital Markets recently raised its target...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NBIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640929953","title":"Neurocrine Biosciences CSO Jude Onyia disposes of common shares worth $1.76 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2640929953","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640929953?lang=en_us&edition=fundamental","pubTime":"2026-06-03 06:08","pubTimestamp":1780438134,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences Chief Scientific Officer Jude Onyia sold 11,000 common shares on June 1 at USD 160.25.The sale followed an exercise of 11,000 shares at USD 84.74.Directly held non-qualified stock options ended at 13,268.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurocrine Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 02, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDL2mQvq2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","LU2065169927.USD","BK4139","LU2065170008.USD","LU2065171311.SGD","LU2324357040.USD","LU0154245756.USD","LU0320765992.SGD","NBIX","LU0109394709.USD","LU2065171402.SGD","LU0889565916.HKD","LU0154245673.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640296709","title":"Neurocrine Biosciences Chief Regulatory Officer Ingrid Delaet disposes of 2,261 common shares for $354,323.31","url":"https://stock-news.laohu8.com/highlight/detail?id=2640296709","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640296709?lang=en_us&edition=fundamental","pubTime":"2026-06-03 06:03","pubTimestamp":1780437830,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences Chief Regulatory Officer Ingrid Delaet sold 2,261 shares on May 29 at USD 156.71.Sale followed the exercise of 2,261 non-qualified stock options at USD 79.02 on the same day.Delaet ended with 16,225 shares of common stock directly owned.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurocrine Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 02, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDL6fXhBS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Neurocrine Biosciences Chief Regulatory Officer Ingrid Delaet disposes of 2,261 common shares for $354,323.31","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU0109394709.USD","LU2065169927.USD","LU0823416689.USD","LU0154245673.USD","LU2065171311.SGD","BK4139","LU0889565916.HKD","LU2065171402.SGD","LU0154245756.USD","LU2065170008.USD","LU2324357040.USD","NBIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640193049","title":"Neurocrine reinstated with a Buy at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2640193049","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640193049?lang=en_us&edition=fundamental","pubTime":"2026-06-02 17:11","pubTimestamp":1780391517,"startTime":"0","endTime":"0","summary":"Goldman Sachs reinstated coverage of Neurocrine (NBIX) with a Buy rating and $213 price target The completion of the Soleno Therapeutics acquisitio...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neurocrine-reinstated-with-a-buy-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neurocrine-reinstated-with-a-buy-at-goldman-sachs-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1868836914.USD","NBIX","LU2237443549.SGD","LU0154245756.USD","LU0048573561.USD","IE00B19Z3B42.SGD","BK4139","LU1868837300.USD","LU1894683264.USD","LU0868494708.USD","LU2065170008.USD","LU0345770308.USD","BK4533","LU2265009873.SGD","LU2750360641.GBP","LU0106831901.USD","LU1791807156.HKD","LU0061475181.USD","LU1668664300.SGD","LU1868836757.USD","BK4552","LU0251142724.SGD","LU0942090050.USD","LU0251131958.USD","LU2471134952.CNY","LU0742534661.SGD","LU0868494617.USD","LU2471134523.USD","LU2237438978.USD","LU2237443382.USD","IE00BFXG1179.USD","LU2237443622.USD","BK4585","LU1804176565.USD","LU2065171311.SGD","IE0004086264.USD","GSX","LU2471134879.HKD","LU1868836591.USD","LU0096364046.USD","LU2237443895.HKD","LU2750360997.AUD","LU0889565916.HKD","LU0345770993.USD","BK4516","LU2237443465.HKD","IE0002270589.USD","LU2324357040.USD","LU0320765992.SGD","BK4504"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640925449","title":"Centene, Deckers and 14 Other 'Dividend Hopefuls' -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2640925449","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640925449?lang=en_us&edition=fundamental","pubTime":"2026-06-02 13:30","pubTimestamp":1780378200,"startTime":"0","endTime":"0","summary":"Investors love companies that grow dividends over time. But guessing which companies will initiate their first dividend can be a way to get in on the ground floor.More than a dozen large-cap companies could be poised to join the dividend club, based on cash holdings and free-cash flow yield, according to Morgan Stanley. The list includes Centene, Deckers, Airbnb and 13 others, according to a report published last week.S&P 500 companies that initiate and grow dividends have retuned 10.2% a year on average going back to 1973, according to Hartford Funds data, that handily beats both companies that simply pay a dividend  and those that don't pay a dividend .\"Dividends can offer a reliable income stream, signal confidence to the market, and help stabilize portfolios during periods of uncertainty and high valuations,\" wrote the Morgan Stanley team led by strategist Todd Castagno.Deckers, maker of Ugg boots and Hoka sneakers, seems like another potential future payer, given its lin","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1732799900.SGD","BK4516","LU0971096721.USD","CNCG","LU1162221912.USD","LU1291159041.SGD","LU2362540622.SGD","TMF","US2Y.BOND","BMRN","US5Y.BOND","LU2028103732.USD","US10Y.BOND","LU2065171402.SGD","LU0154245673.USD","LU0158827781.USD","IE0002270589.USD","LU0234570918.USD","BK4534","LU1244550577.SGD","DECK","LU2357305700.SGD","US6M.BOND","TLT","CNC","LU1201861165.SGD","TLTW","LU0225283273.USD","LU0648001328.SGD","VIG","INCY","LU1989772923.USD","LU0053666078.USD","LU0320765992.SGD","LU1791710400.SGD","US3Y.BOND","NBIX","LU0859254822.USD","LU1064131342.USD","US30Y.BOND","LU0823416689.USD","LU0557290698.USD","LU0912757837.SGD","LU0477156797.USD","US12M.BOND","LU0980610538.SGD","US7Y.BOND","LU0314104364.USD","BK4567","LU0795875169.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639702016","title":"Neurocrine Biosciences CSO Jude Onyia sells 11,000 shares for $1.71 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2639702016","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639702016?lang=en_us&edition=fundamental","pubTime":"2026-05-30 06:10","pubTimestamp":1780092633,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences Chief Scientific Officer Jude Onyia exercised options for 11,000 common shares at USD 84.74 on May 27.Onyia sold 11,000 common shares at an average USD 155.53 on May 27.He reported direct ownership of 25,846 common shares following the transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurocrine Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 29, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDLbR1GyR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Neurocrine Biosciences CSO Jude Onyia sells 11,000 shares for $1.71 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065171402.SGD","LU0109394709.USD","LU2065170008.USD","LU2065169927.USD","NBIX","LU0320765992.SGD","BK4139","LU0154245756.USD","LU2324357040.USD","LU0889565916.HKD","LU0823416689.USD","LU0154245673.USD","LU2065171311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639467918","title":"Neurocrine Biosciences Should See More Upside on Crenessity Growth, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2639467918","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639467918?lang=en_us&edition=fundamental","pubTime":"2026-05-30 00:21","pubTimestamp":1780071663,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences  could see more upside from wider Crenessity use, easing insurance limits, stronger patient demand and likely commercial product beats in 2026, RBC Capital Markets said in a note Friday.RBC said its survey of 35 endocrinologists showed Crenessity still has room to grow after a strong Q1, even as some investors worry near-term demand may slow as surveyed doctors now use Crenessity in about 23% of their Congenital Adrenal Hyperplasia patients on average and expect usage to reach 37% by the end of 2026.The firm raised its 2026 Crenessity sales estimate to $750 million from $734 million, above the roughly $650 million consensus estimate, saying the target looks achievable even with more cautious growth assumptions and longer-term demand also looks strong, with doctors expecting to use Crenessity in just over half of their CAH patients within five years.Insurance approvals remain the main barrier to wider use, but RBC expects those issues to ease over time and support","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2324357040.USD","LU0109394709.USD","LU0154245673.USD","LU0154245756.USD","LU2065169927.USD","LU2065170008.USD","LU0320765992.SGD","LU2065171402.SGD","LU2065171311.SGD","LU0823416689.USD","BK4139","NBIX","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639762416","title":"RBC Lifts Price Target on Neurocrine Biosciences to $183 From $180, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2639762416","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639762416?lang=en_us&edition=fundamental","pubTime":"2026-05-29 19:28","pubTimestamp":1780054080,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences (NBIX) has an average rating of buy and mean price target of $192.17, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from m","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NBIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639611018","title":"Neurocrine Chief Corporate Affairs Officer David W. Boyer disposes of 3,888 shares worth $609,019.12","url":"https://stock-news.laohu8.com/highlight/detail?id=2639611018","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639611018?lang=en_us&edition=fundamental","pubTime":"2026-05-29 06:09","pubTimestamp":1780006173,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences Chief Corporate Affairs Officer David W. Boyer sold 3,888 common shares on May 26.Shares sold at a weighted average price of $156.64.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurocrine Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 28, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nNDL2JBCp9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Neurocrine Chief Corporate Affairs Officer David W. Boyer disposes of 3,888 shares worth $609,019.12","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU2065169927.USD","LU0154245673.USD","LU0109394709.USD","LU2065170008.USD","LU0823416689.USD","LU0154245756.USD","NBIX","LU2065171402.SGD","LU0320765992.SGD","LU2065171311.SGD","BK4139","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639616869","title":"Neurocrine Biosciences shareholders approved amended 2025 equity incentive plan at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2639616869","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639616869?lang=en_us&edition=fundamental","pubTime":"2026-05-29 04:08","pubTimestamp":1779998912,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences held its annual shareholder meeting on May 27, 2026.An amendment to the 2025 Equity Incentive Plan was adopted.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurocrine Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 28, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nNDL9WK3JY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065170008.USD","LU2324357040.USD","LU0823416689.USD","LU0320765992.SGD","LU0109394709.USD","LU2065169927.USD","NBIX","LU0154245756.USD","BK4139","LU0889565916.HKD","LU2065171311.SGD","LU0154245673.USD","LU2065171402.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638650075","title":"Beyond Next Ventures leads SCOHIA PHARMA private funding round raising JPY 3 billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2638650075","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638650075?lang=en_us&edition=fundamental","pubTime":"2026-05-28 15:13","pubTimestamp":1779952386,"startTime":"0","endTime":"0","summary":"Beyond Next Ventures led a private financing round for SCOHIA PHARMA that raised JPY 3 billion, announced May 28, 2026.SCOHIA PHARMA develops small- and medium-molecule drugs for metabolic, endocrine, cardiovascular diseases; founded in 2017 via a Takeda carve-out.Lead obesity and diabetes asset SCO-094 was out-licensed to Huadong Medicine; once-weekly formulation is in Phase 3 trials in China.In April 2026, SCOHIA PHARMA signed an exclusive worldwide license with Neurocrine for MC2R antagonist SCO-483 with milestones up to USD 550 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beyond Next Ventures Inc published the original content used to generate this news brief on May 28, 2026, and is solely responsible for the information","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nNDL7DfzMR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","000963","BK0175","LU1969619763.USD","BK0187","LU2065171402.SGD","LU0154245673.USD","BK0183","LU2065170008.USD","LU2324357040.USD","LU2065169927.USD","BK0188","LU0154245756.USD","BK0196","LU0320765992.SGD","LU2328871848.SGD","NBIX","BK0209","LU2065171311.SGD","LU0823416689.USD","BK0132","BK4139","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638688751","title":"New Real‑World INGREZZA Data in Mild TD Might Change The Case For Investing In Neurocrine Biosciences (NBIX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2638688751","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638688751?lang=en_us&edition=fundamental","pubTime":"2026-05-27 20:07","pubTimestamp":1779883673,"startTime":"0","endTime":"0","summary":"Earlier this month, Neurocrine Biosciences reported new real-world survey data showing that adults with clinician-rated mild tardive dyskinesia treated with INGREZZA often experienced fewer involuntary movements and broad functional gains, many within four weeks.\nThe findings, aligned with American Psychiatric Association guidance, suggest INGREZZA’s benefits may extend beyond symptom control to improvements in independence, daily activities and ability to work for patients with mild...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nbix/neurocrine-biosciences/news/new-realworld-ingrezza-data-in-mild-td-might-change-the-case","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nbix/neurocrine-biosciences/news/new-realworld-ingrezza-data-in-mild-td-might-change-the-case","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2324357040.USD","LU2065170008.USD","BK4566","BK4207","BK4585","LU0154245673.USD","LU0154245756.USD","LU2065171402.SGD","LU0109394709.USD","TD","LU0889565916.HKD","LU2065171311.SGD","BK4139","LU2065169927.USD","NBIX","LU0823416689.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638540353","title":"Neurocrine executives to speak at William Blair growth stock conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2638540353","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638540353?lang=en_us&edition=fundamental","pubTime":"2026-05-27 04:01","pubTimestamp":1779825696,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences executives will present at investor conferences in early June.Fireside chat set for June 2, 2026 at the William Blair 46th Annual Growth Stock Conference in Chicago.Second fireside chat scheduled for June 9, 2026 at the Goldman Sachs 47th Annual Global Healthcare Conference 2026 in Miami.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nNDL9KwxF1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","LU2324357040.USD","LU1868836914.USD","BK4550","GSX","LU0106831901.USD","LU1894683348.USD","IE0004086264.USD","LU0889565916.HKD","LU1868836757.USD","LU1868836591.USD","LU2237443382.USD","LU2750360997.AUD","LU0154245756.USD","IE00BFXG1179.USD","BK4504","BK4552","LU0061475181.USD","BK4585","BK4139","LU1868837300.USD","IE00B19Z3581.USD","LU1868837136.USD","IE00BSNM7G36.USD","LU0251142724.SGD","BK4533","LU2237443978.SGD","LU0868494617.USD","LU2750360641.GBP","BK4588","LU2237438978.USD","LU1668664300.SGD","LU0345770993.USD","NBIX","LU2237443622.USD","LU2237443549.SGD","LU2471134796.USD","LU1791807156.HKD","IE0034235188.USD","IE0004091025.USD","LU0868494708.USD","LU0742534661.SGD","LU0251131958.USD","BK4127","LU0048573561.USD","LU2065171311.SGD","LU0154245673.USD","LU0109394709.USD","LU1894683264.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":199,"code":"91000000","status":"200"}]}}